Example: Heart Attack

Clinical Trials Sponsored by APT Pharmaceuticals, Inc

Total 3 results

NCT00938236

Terminated

CIS001 Extension Study of Cyclosporine Inhalation Solution

Conditions: Lung Transplant
NCT00755781

Completed

Study of Cyclosporine Inhalation Solution (CIS) in Improving Bronchiolitis Obliterans Syndrome-Free Survival Following Lung Transplantation

Conditions: Lung Transplant
NCT00633373

No longer available

Cyclosporine Inhalation Solution (CIS) in Lung Transplant Recipients

Conditions: Lung Transplant